Genscript Biotech Statistics
Total Valuation
HKG:1548 has a market cap or net worth of HKD 35.07 billion. The enterprise value is 32.06 billion.
| Market Cap | 35.07B |
| Enterprise Value | 32.06B |
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:1548 has 2.19 billion shares outstanding. The number of shares has increased by 4.08% in one year.
| Current Share Class | 2.19B |
| Shares Outstanding | 2.19B |
| Shares Change (YoY) | +4.08% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.22% |
| Owned by Institutions (%) | 15.92% |
| Float | 1.38B |
Valuation Ratios
The trailing PE ratio is 1.44 and the forward PE ratio is 58.68.
| PE Ratio | 1.44 |
| Forward PE | 58.68 |
| PS Ratio | 5.40 |
| PB Ratio | 1.01 |
| P/TBV Ratio | 1.02 |
| P/FCF Ratio | 34.81 |
| P/OCF Ratio | 19.56 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 220.51, with an EV/FCF ratio of 31.81.
| EV / Earnings | 1.31 |
| EV / Sales | 4.93 |
| EV / EBITDA | 220.51 |
| EV / EBIT | n/a |
| EV / FCF | 31.81 |
Financial Position
The company has a current ratio of 1.96, with a Debt / Equity ratio of 0.12.
| Current Ratio | 1.96 |
| Quick Ratio | 1.78 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 2.20 |
| Debt / FCF | 4.27 |
| Interest Coverage | 12.85 |
Financial Efficiency
Return on equity (ROE) is -1.94% and return on invested capital (ROIC) is 2.88%.
| Return on Equity (ROE) | -1.94% |
| Return on Assets (ROA) | 2.56% |
| Return on Invested Capital (ROIC) | 2.88% |
| Return on Capital Employed (ROCE) | 3.71% |
| Revenue Per Employee | 1.13M |
| Profits Per Employee | 4.23M |
| Employee Count | 5,568 |
| Asset Turnover | 0.19 |
| Inventory Turnover | 8.23 |
Taxes
In the past 12 months, HKG:1548 has paid 138.10 million in taxes.
| Income Tax | 138.10M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +26.78% in the last 52 weeks. The beta is 0.95, so HKG:1548's price volatility has been similar to the market average.
| Beta (5Y) | 0.95 |
| 52-Week Price Change | +26.78% |
| 50-Day Moving Average | 16.98 |
| 200-Day Moving Average | 14.03 |
| Relative Strength Index (RSI) | 44.80 |
| Average Volume (20 Days) | 8,192,380 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:1548 had revenue of HKD 6.50 billion and earned 24.43 billion in profits. Earnings per share was 11.04.
| Revenue | 6.50B |
| Gross Profit | 3.61B |
| Operating Income | 1.41B |
| Pretax Income | -337.46M |
| Net Income | 24.43B |
| EBITDA | 1.86B |
| EBIT | 1.41B |
| Earnings Per Share (EPS) | 11.04 |
Balance Sheet
The company has 7.37 billion in cash and 4.31 billion in debt, giving a net cash position of 3.06 billion or 1.40 per share.
| Cash & Cash Equivalents | 7.37B |
| Total Debt | 4.31B |
| Net Cash | 3.06B |
| Net Cash Per Share | 1.40 |
| Equity (Book Value) | 34.71B |
| Book Value Per Share | 15.92 |
| Working Capital | 4.52B |
Cash Flow
In the last 12 months, operating cash flow was 1.79 billion and capital expenditures -785.29 million, giving a free cash flow of 1.01 billion.
| Operating Cash Flow | 1.79B |
| Capital Expenditures | -785.29M |
| Free Cash Flow | 1.01B |
| FCF Per Share | 0.46 |
Margins
Gross margin is 55.46%, with operating and profit margins of 21.67% and 375.74%.
| Gross Margin | 55.46% |
| Operating Margin | 21.67% |
| Pretax Margin | -5.19% |
| Profit Margin | 375.74% |
| EBITDA Margin | 28.64% |
| EBIT Margin | 21.67% |
| FCF Margin | 15.50% |
Dividends & Yields
HKG:1548 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.08% |
| Shareholder Yield | -4.08% |
| Earnings Yield | 69.64% |
| FCF Yield | 2.87% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:1548 has an Altman Z-Score of 2.91 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.91 |
| Piotroski F-Score | 6 |